be_ixf;ym_202411 d_26; ct_50

Latest Insights on OGI

buy stocks omicron dip Buy the Omicron Dip! (But Choose Wisely) Markets went haywire this week (and last) in response to a double whammy: Omicron’s appearance on the COVID stage and a suddenly hawkish Fed. Stocks dropped across the board … but some dropped more than others. That confirms what I’ve been saying for most of 2021: The market increasingly prefers quality and consistent earnings growth […]
Delta airlines travel concerns Omicron Threatens Airline Companies: Here We Go Again… (5-minute read) Since the pandemic started, air travel has completely changed. Here’s why you shouldn’t touch airlines or other travel-related companies with a 10-foot pole…
metaverse investing Profit From the Metaverse Frenzy in 2022 We’re going to see an explosion in the number of investable opportunities in the metaverse space.
2022 investing predictions 2 Major Predictions for 2022 Looking forward to 2022, I have two major predictions.
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This